Viewing StudyNCT01347866



Ignite Creation Date: 2024-05-05 @ 11:28 PM
Last Modification Date: 2024-10-26 @ 10:35 AM
Study NCT ID: NCT01347866
Status: TERMINATED
Last Update Posted: 2018-10-29
First Post: 2011-05-02

Brief Title: Clinical Study Of PI3KmTOR Inhibitors In Combination With An Oral MEK Inhibitor Or Irinotecan In Patients With Advanced Cancer
Sponsor: Pfizer
Organization: Pfizer

Conditions & Keywords Data

Conditions:
Name
Advanced Cancer
Keywords:
Name View
Advanced metastatic cancer solid tumors View
PI3K View
mTOR View
MEK View